Viewing Study NCT00207051


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2026-01-10 @ 3:30 PM
Study NCT ID: NCT00207051
Status: COMPLETED
Last Update Posted: 2011-01-25
First Post: 2005-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module